Jung Un Shin
Areas of Focus
Overview
Jung is an associate in Crowell & Moring’s Patents Group. Her practice focuses on securing robust patents for clients across diverse technologies and offering strategic intellectual property guidance. Jung's experience encompasses counseling clients on patent infringement and invalidity investigations, licensing, and trade secret matters.
Career & Education
- University of Wisconsin Law School, J.D., 2024
- Korea Advanced Institute of Science and Technology, Master’s Degree, Intellectual Property, 2016
- Hanyang University, B.S., cum laude, Chemistry, 2010
- Illinois
- U.S. Patent and Trademark Office (USPTO)
- Korean Patent Attorney
- Korean Patent Attorneys Association
- Illinois Bar Association
- Korean
Jung's Insights
Client Alert | 4 min read | 03.02.26
Ex parte reexamination is seeing a resurgence in popularity as a cost-effective means to challenge a patent’s validity and should be part of your patent strategy. An ex parte reexamination is a proceeding in which any party — including a patent owner or an anonymous third party — may submit prior art to request that the United States Patent and Trademark Office (USPTO) reassess an issued patent's validity. Once overshadowed by the introduction of inter partes review (IPR) and post-grant review (PGR) following the enactment of the America Invents Act in 2012, ex parte reexamination is now experiencing a significant resurgence as a strategic alternative to both proceedings. This client alert explains what is driving ex parte reexamination’s resurgence and what it means for your patent strategy.
Client Alert | 3 min read | 07.21.25
Bypass Applications in U.S. Patent Practice: A Strategic Alternative to National Stage Entry
Client Alert | 4 min read | 04.01.25
Hatch-Waxman PTE for Reissue Patents Should Be Calculated From the Original Patent’s Issue Date
Insights
Jung's Insights
Client Alert | 4 min read | 03.02.26
Ex parte reexamination is seeing a resurgence in popularity as a cost-effective means to challenge a patent’s validity and should be part of your patent strategy. An ex parte reexamination is a proceeding in which any party — including a patent owner or an anonymous third party — may submit prior art to request that the United States Patent and Trademark Office (USPTO) reassess an issued patent's validity. Once overshadowed by the introduction of inter partes review (IPR) and post-grant review (PGR) following the enactment of the America Invents Act in 2012, ex parte reexamination is now experiencing a significant resurgence as a strategic alternative to both proceedings. This client alert explains what is driving ex parte reexamination’s resurgence and what it means for your patent strategy.
Client Alert | 3 min read | 07.21.25
Bypass Applications in U.S. Patent Practice: A Strategic Alternative to National Stage Entry
Client Alert | 4 min read | 04.01.25
Hatch-Waxman PTE for Reissue Patents Should Be Calculated From the Original Patent’s Issue Date
